Aqr Capital Management LLC Cassava Sciences Inc Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $83,805 - $262,039	5,132 New	5,132 $215,000
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $195,825 - $437,480	-11,372 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $8,541 - $13,899	-262 Reduced 2.25%	11,372 $422,000
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $956 - $2,363	-26 Reduced 0.22%	11,634 $508,000
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $236,614 - $766,068	-5,662 Reduced 32.69%	11,660 $724,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $6,430 - $17,944	200 Added 1.17%	17,322 $1.48 Million
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $76,394 - $947,661	-10,775 Reduced 38.62%	17,122 $770,000
Q4 2020 Feb 16, 2021	SELL	$6.79 - $12.25 $220,491 - $397,794	-32,473 Reduced 53.79%	27,897 $190,000
Q3 2020 Nov 16, 2020	BUY	$2.86 - $11.51 $172,658 - $694,858	60,370 New	60,370 $695,000

196

13.8M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.